Management of early invasive breast cancer in very young women (<35 years)

Clinical Breast Cancer

Volumn 11, Issue 4, 2011, Pages 196-203

  Hartmann, Steffi ^a   Reimer, Toralf ^a   Gerber, Bernd ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Breast cancer; Contraception; Fertility; Genetic counseling; Young women

Indexed keywords

ANASTROZOLE; GONADORELIN; TAMOXIFEN;

AWARENESS; AXILLARY LYMPH NODE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; DELAYED DIAGNOSIS; EARLY CANCER; FEMALE FERTILITY; GENETIC COUNSELING; HIGH RISK POPULATION; HUMAN; LYMPH NODE BIOPSY; MASTECTOMY; META ANALYSIS; PRACTICE GUIDELINE; PREGNANCY; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION;

EID: 80052763410     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2011.06.001     Document Type: Review

References (97)

1. National Cancer Institute Surveillance Epidemiology and End Results Program, Surveillance, SEER Stat Fact Sheets: Breast http://www.seer.cancer.gov/ statfacts/html/breast.html Accessed August 28, 2010
2. S.H. Ahn, B.H. Son, and S.W. Kim Poor outcome of the hormone receptor-positive breast cancer at very young age is due to tamoxifen resistence: nation wide survival data in Korea-a report from the Korean Breast Cancer Society J Clin Oncol 25 2007 2360 2368
3. W. Han, S.W. Kim, and I.A. Park Young age: an independent risk factor for disease-free survival in women with operable breast cancer BMC Cancer 4 2004 82
4. W. Han, S.Y. Kang Korean Breast Cancer Society Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer Breast Cancer Res Treat 119 2009 193 200
5. N.S. El Shagir, M. Seoud, and M.K. Khalil Effects of young age at presentation on survival in breast cancer BMC Cancer 6 2006 194
6. I.L. Wapnir, S.J. Anderson, and E.P. Mamounas Prognosis after ipsilateral breast cancer recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials J Clin Oncol 24 2006 2028 2037 (Pubitemid 46622111)
7. C.K. Anders, D.S. Hsu, and G. Broadwater Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 2008 3324 3330
8. Varga D, Koenig J, Kuhr K, et al. Comparison of early onset breast cancer patients to older premenopausal breast cancer patients. Arch Gynecol Obstet Published online January 3, 2010.
9. A. Katalinic, and R. Pritzkuleit Waldmann A recent trend in breast cancer incidence and mortality in Germany Breast Care 4 2009 75 80
10. N. Houssami, L. Irwig, and J.M. Simpson Sydney Breast Imaging Accuracy Study: Comparative sensitivity and specificity of mammography and sonography in young women with symptoms AJR Am J Roentgenol 180 2003 935 940 (Pubitemid 36363028)
11. H. Wright, J. Listinsky, and A. Rim Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women Am J Surg 190 2005 572 575 (Pubitemid 41306078)
12. L. Turnbull, S. Brown, and I. Harvey Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial Lancet 375 2010 563 571
13. The American Society of Breast Surgeons Position statement on the use of magnetic resonance imaging in breast surgical oncology http://www. breastsurgeons.org/statements/PDF-statements/MRI.pdf Accessed November 11, 2010
14. T.B. Bevers, B.O. Anderson, and E. Bonaccio NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis J Natl Compr Canc Netw 7 2009 1060 1096
15. T.O. Henderson, A. Amsterdam, and S. Bathia Surveillance for breast cancer in women treated with chest radiation for a childhood, adolescent or young adult cancer: a report from the children's oncology group Ann Intern Med 152 2010 444 455
16. C.K. Kuhl, S. Schrading, and C.C. Leutner Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer J Clin Oncol 23 2005 8469 8476
17. R. Schmutzler, B. Schlegelberger, and A. Meindl Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD Zentralbl Gynakol 125 2003 494 506 [in German] (Pubitemid 38089706)
18. B. Gerber, A. Krause, and M. Dieterich The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study Ann Surg 249 2009 461 468
19. N. Klauber-Demore, B.F. Calvo, and C.S. Hultman Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients Am J Surg 190 2005 595 597 (Pubitemid 41306084)
20. N.S. Russell, I.H. Kunkler, and G. van Tienhoven Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate? J Clin Oncol 27 2009 996 997
21. L.B. Marks, J. Zeng, and L.R. Prosnitz One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate J Clin Oncol 26 2008 2075 2077
22. G.H. de Bock, J.A. van der Hage, and H. Putter Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies Eur J Cancer 42 2006 351 356 (Pubitemid 43132890)
23. A.C. Voogd, M. Nielsen, and J.L. Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697 (Pubitemid 32230869)
24. N. Kroman, H. Holtveg, and J. Wohlfahrt Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma Cancer 100 2004 688 693 (Pubitemid 38176844)
25. B.C. Turner, E. Harrold, and E. Matloff BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy or radiation therapy: implications for breast conserving management in patients with BRCA1/BRCA2 mutations J Clin Oncol 17 1999 3017 3024 (Pubitemid 29470628)
26. B.G. Haffty, E. Harrold, and A.J. Khan Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 2002 1471 1477 (Pubitemid 34457765)
27. C. Seynaeve, L.C. Verhoog, and L.M. van de Bosch Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy Eur J Cancer 40 2004 1150 1158 (Pubitemid 38526333)
28. C.A. Garcia-Etienne, M. Barile, and O.D. Gentilini Breast conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? Ann Surg Oncol 16 2009 3380 3387
29. L.J. Pierce, M. Strawderman, and S.A. Narod Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol 18 2000 3360 3369
30. M. Robson, T. Svahn, and B. McCormick Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic based series Cancer 103 2005 44 51 (Pubitemid 39665455)
31. Y.M. Kirova, D. Stoppa-Lyonnet, and A. Savignoni Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Eur J Cancer 41 2005 2304 2311 (Pubitemid 41415607)
32. L.J. Pierce, A.M. Levin, and T.R. Rebbeck Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol 24 2006 2437 2443 (Pubitemid 46630619)
33. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106 (Pubitemid 41797643)
34. H. Bartelink, J.C. Horiot, and P.M. Poortmans Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 2007 3259 3265 (Pubitemid 47325610)
35. B.V. Offersen, M. Overgaard, N. Kroman, and J. Overgaard Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review Radiother Oncol 90 2009 1 13
36. B.D. Smith, D.W. Arthur, and T.A. Buchholz Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys 74 2009 987 1001
37. AGO Breast Commission Diagnosis and treatment of patients with primary and metastatic breast cancer Guidelines of the AGO breast commission http://www.ago-online.de/index.php?lang=de&site=mamma-guide- topical&topic=mamma-guide Accessed August 28, 2010
38. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
39. S.M. Swain, J.H. Jeong, and C.E. Geyer Jr Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer N Engl J Med 362 2010 2053 2065
40. B. Gerber, M. Dieterich, H. Mller, and T. Reimer Controversies in preservation of ovary function and fertility in patients with breast cancer Breast Cancer Res Treat 108 2007 1 7
41. S. Goel, R. Sharma, A. Hamilton, and J. Beith LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women Cochrane Database Syst Rev 4 2009 CD004562
42. J. Cuzick, L. Ambroisine LHRH-agonists in Early Breast Cancer Overview group Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials Lancet 369 2007 1711 1723
43. M. Gnant, B. Mlineritsch, and W. Schippinger Endocrine therapy plus zoledronic acid in premenopausal breast cancer N Engl J Med 360 2009 679 691
44. T. Reimer, and B. Gerber Endocrine therapy plus zoledronic acid in premenopausal breast cancer N Engl J Med 360 2009 2368
45. Statistisches Bundesamt Deutschland Bevölkerung - Geburten http://www.destatis.de/ Accessed August 28, 2010
46. M. Hickey, M. Peate, C.M. Saunders, and M. Friedlander Breast cancer in young women and its impact on reproductive function Hum Reprod Update 15 2009 323 339
47. P.B. Gupta, and C. Kupferwasser Contributions of estrogen to ER-negative breast tumor growth J Steroid Biochem Mol Biol 102 2006 71 78 (Pubitemid 44750648)
48. K. Oktay, E. Buyuk, and N. Libertella Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation J Clin Oncol 23 2005 4747 4753
49. K.A. Rodriguez-Wallberg, and K. Oktay Fertility preservation in women with breast cancer Clin Obstet Gynecol 53 2010 753 762
50. S. Lee, S. Ozkavukcu, and E. Heytens Value of early referral to fertility preservation in young women with breast cancer J Clin Oncol 28 2010 4683 4686
51. B. Gerber, H. Stehle, and F. Ricardo ZORO: a prospective randomized multicenter study to prevent chemotherapy-induced ovarian failure with the GnRH-agonist goserelin in young hormone-insensitive breast cancer patients receiving anthracycline-containing (neo-)adjuvant chemotherapy (GBG 37) J Clin Oncol 27 2009 15s (Abstract #526)
52. R.C. Leonard, D. Adamson, and R. Anderson The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer J Clin Oncol 28 2010 89s (Abstract #590)
53. A. Badawy, A. Elnashar, M. El-Ashry, and M. Shahat Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Fertil Steril 91 2009 694 697
54. L. Del Mastro, L. Boni, and A. Michelotti Role of luteinizing hormone-releasing hormone analog (LHRHa) triptorelin (T) in preserving ovarian function during chemotherapy for early breast cancer patients: results of a multicenter phase III trial of Gruppo Italiano Mammella (GIM) group J Clin Oncol 28 2010 74s (Abstract #528)
55. B.M. Beadle, W.A. Woodward, and L.P. Middleton The impact of pregnancy on breast cancer outcomes in women < or=35 years Cancer 115 2009 1174 1184
56. T.T. White Prognosis of breast cancer for pregnant and nursing women Surg Gynecol Obstet 100 1955 661 666
57. J.M. Anderson Mammary cancers and pregnancy BMJ 1 1979 1124 1127 (Pubitemid 9153244)
58. S. Loibl, G. von Minckwitz, and K. Gwyn Breast carcinoma during pregnancy International recommendations from an expert meeting Cancer 106 2006 237 246 (Pubitemid 43100430)
59. S. Tretli, G. Kvalheim, S. Thoresen, and H. Høst Survival of breast cancer patients diagnosed during pregnancy or lactation Br J Cancer 58 1988 382 384
60. J.C. Woo, T. Yu, and T.C. Hurd Breast cancer in pregnancy: a literature review Arch Surg 138 2003 91 98 (Pubitemid 36055657)
61. D. Zemlickis, M. Lishner, and P. Degendorfer Maternal and fetal outcome after breast cancer in pregnancy Am J Obstet Gynecol 166 1992 781 787
62. L. Liberman, C. Giess, and D.D. Dershaw Imaging of pregnancy associated breast cancer Radiology 191 1994 245 248 (Pubitemid 24098239)
63. A.H. Nicklas, and M.E. Baker Imaging strategies in the pregnant cancer patient Semin Oncol 27 2000 623 632
64. E.M. Schackmuth, C.L. Harlow, and L.W. Norton Milk fistula: a complication after core biopsy AJR Am J Roentgenol 161 1993 961 962 (Pubitemid 23333152)
65. S.Y. Khera, J.V. Kiluk, and D.M. Hasson Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping Breast J 14 2008 250 254 (Pubitemid 351678056)
66. O. Gentilini, M. Cremonesi, and A. Toesca Sentinel lymph node biopsy in pregnant patients with breast cancer Eur J Nucl Med Mol Imaging 37 2009 78 83
67. H.B. Kal, and H. Struikmans Breast cancer during pregnancy International recommendations from an expert meeting Cancer 107 2006 882 883 (Pubitemid 44232681)
68. D.L. Berry, R.L. Theriault, and F.A. Holmes Management of breast cancer during pregnancy using a standardized protocol J Clin Oncol 17 1999 855 861 (Pubitemid 29109315)
69. O. Mir, P. Berveiller, and S. Ropert Emerging therapeutic options for breast cancer chemotherapy during pregnancy Ann Oncol 19 2007 607 613
70. M.J. Goodyer, J.R. Ismail, and S.P. O'Reilly Safety of trastuzumab (Herceptin) during pregnancy: two case reports Cases J 2 2009 9329
71. G.R. Cunha, O. Taguchi, and R. Namikawa Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract Hum Pathol 18 1987 1132 1143 (Pubitemid 18000298)
72. S.L. Cullins, G. Pridjian, and C.M. Sutherland Goldenhar's syndrome associated with tamoxifen given to the mother during gestation JAMA 271 1994 1905a 1906a
73. K. Tewari, R.G. Bonebrake, T. Asrat, and A.M. Shanberg Ambiguous genitalia in infant exposed to tamoxifen in utero Lancet 350 1997 183 (Pubitemid 27303627)
74. T. Saphner, D.C. Tormey, and R. Gray Annual hazard rates of recurrence for breast cancer after primary therapy J Clin Oncol 14 1996 2738 2746 (Pubitemid 26329660)
75. A. Ives, C. Saunders, M. Bulsara, and J. Semmens Pregnancy after breast cancer: population based study BMJ 334 2007 194
76. R. Sankila, S. Heinvaara, and T. Hakulinen Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect Am J Obstet Gynecol 170 1994 818 823 (Pubitemid 24224706)
77. D. Mintzer, J. Glassburn, B.A. Mason, and D. Sataloff Breast cancer in the very young patient: a multidisciplinary case presentation Oncologist 7 2002 547 554 (Pubitemid 36013438)
78. E. Cardonick, and A. Iacobucci Use of chemotherapy during human pregnancy Lancet Oncol 5 2004 283 291 (Pubitemid 38541580)
79. A. Aviles, and N. Neri Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero Clin Lymphoma 2 2001 173 177 (Pubitemid 34092723)
80. L. Barthelmes, L.A. Davidson, and C. Gaffney Clinical review: pregnancy and breast cancer BMJ 330 2005 1375 1378 (Pubitemid 40839572)
81. M. Helewa, P. Lvesque, and D. Provencher Breast cancer, pregnancy, and breastfeeding J Obstet Gynaecol Can 24 2002 164 180
82. E. de Bree, A. Makrigiannakis, and J. Askoxylakis Pregnancy after breast cancer A comprehensive review J Surg Oncol 101 2010 534 542
83. M.S. Moran, J.M. Colasanto, and B.G. Haffty Effects of breast-conserving therapy on lactation after pregnancy Cancer J 11 2005 399 403 (Pubitemid 41725731)
84. D.L. Kleinberg, J. Todd, and G. Babitsky Inhibition by estradiol on the lactogenic effect of prolactin in primate mammary tissue: reversal by antiestrogens LY156758 and tamoxifen Proc Natl Acad Sci USA 80 1983 4144 4148 (Pubitemid 13072784)
85. M. Sagi, N. Weinberg, and A. Eilat Preimplantation genetic diagnosis for BRCA1/2- a novel clinical experience Prenat Diagn 29 2009 508 513
86. B. van der Burg, E. Kalkhoven, L. Isbrcker, and S.W. de Laat Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions J Steroid Biochem Mol Biol 42 1992 457 465
87. T. Backman, I. Rauramo, and K. Jaakkola Use of levonorgestrel-releasing intrauterine system and breast cancer Obstet Gynecol 106 2005 813 817 (Pubitemid 41362188)
88. X.B. Trinh, W.A. Tjalma, and A.P. Makar Use of levonorgestrel-releasing intrauterine system in breast cancer patients Fertil Steril 90 2008 17 22 (Pubitemid 351885178)
89. A. Meindl German Consortium for Hereditary Breast and Ovarian Cancer Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population Int J Cancer 97 2002 472 480 (Pubitemid 34027806)
90. P.C. Fong, D.S. Boss, and T.A. Yap Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers N Engl J Med 361 2009 123 134
91. S. Rottenberg, J.E. Jaspers, and A. Kersbergen High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs Proc Natl Acad Sci USA 105 2008 17079 17084
92. T. Byrski, J. Gronwald, and T. Huzarski Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers Breast Cancer Res Treat 108 2007 289 296
93. T. Byrski, T. Huzarski, and R. Dent Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients Breast Cancer Res Treat 115 2008 359 363
94. K. Metcalfe, H.T. Lynch, and P. Ghadirian Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2004 2328 2335 (Pubitemid 41115389)
95. L.J. Pierce, K.A. Phillips, and K.A. Griffith Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy Breast Cancer Res Treat 121 2010 389 398
96. K.A. Metcalfe, H.T. Lynch, and P. Ghadirian The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers Gynecol Oncol 96 2005 222 226 (Pubitemid 39612440)
97. S.M. Domchek, T.M. Friebel, and C.F. Singer Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA 304 2010 967 975